The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer

By Bjork T.   Piironen T.   Pettersson K.   Lovgren T.   Stenman U.-H.   Oesterling J.E.   Abrahamsson P.-A.   Lilja H.  

Urology, Vol. 48, Iss. 6, 1996-12 ,pp. : 882-888

Elsevier

Access to resources Recommend Favorite

Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer

By Thiel R.   Pearson J.D.   Epstein J.I.   Walsh P.C.   Carter H.B.  

Urology, Vol. 49, Iss. 5, 1997-05 ,pp. : 716-720

Elsevier

Access to resources Recommend Favorite

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

By Kupelian P.   Katcher J.   Levin H.   Zippe C.   Klein E.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 249-260

Elsevier

Access to resources Recommend Favorite